Sharing Progress in Cancer Care

Startseite
Schweiz
Bellinzona
Sharing Progress in Cancer Care

SPCC is a non-profit association, based in Switzerland, working in the field of cancer education.

01/06/2026

SPCC is organising a live, in-person symposium, which took place during the MASCC/ISOO 2026 Annual Meeting in Melbourne, Australia (June 25-27, 2026).

🔬 This symposium will convene leading experts to explore the current landscape and unmet needs in management, discuss insights from recent clinical trials on risk assessment, and highlight the patient experience through real-world perspectives.

The session aims to address persistent gaps in current practice by offering updated, evidence-based insights.

The symposium recording and the related on-demand materials will be made available via OncoCorner.

👉🏼 Learn more: https://www.spcc.net/events-and-activities/onsite-events/?id=121633

This educational activity is supported by an unrestricted educational grant from Helsinn Healthcare SA and is organised by SPCC.

Multinational Association of Supportive Care in Cancer - MASCC

28/05/2026

How can we translate complex tumour biology into everyday clinical care?

Join us for the sixth session of the Definitive Trial Project, a European Commission-funded clinical trial demonstrating how the HER2DX® diagnostic assay can personalise treatment decisions and improve quality of life for patients with early-stage HER2-positive breast cancer, without compromising outcomes.

Programme:
HER2DX: biological bases – Francesco Schettini (ES)
HER2DX: clinical perspective – Marta González (ES)
Discussion and Q&A – Moderated by Aleix Prat (ES)

Access is free of charge, but registration is mandatory.

👉 Register here: https://www.oncocorner.net/index.php?p=events&id=A-528

Funded by the European Union – Horizon Europe Grant Agreement No. 101136953.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.
This work has also received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).

26/05/2026

Did you recently explore OncoCorner?
Our digital hub brings together curated content and forward-looking perspectives from across the global cancer care community.

A platform grounded in SPCC’s commitment to improving outcomes for every patient, everywhere.

👉🏼 https://www.oncocorner.net/ 👈🏼

Make sure to unlock everything this space has to offer, which is made possible thanks to the continuous commitment of the companies part of the Sustaining Corporate Programme. We would also like to acknowledge the unconditional support of Astrazeneca S.p.A.

22/05/2026

Did you miss our live session on gastrointestinal oncology and medical nutrition? The full webinar, "GI oncology pathways: from prehab to advanced cancer", is now available on-demand! You can watch the recording at your convenience and at your own pace.
👉🏼 https://www.oncocorner.net/index.php?p=events&id=A-530 👈🏼

What was discussed:
- Medical nutrition in pancreatic cancer care pathways: best practices with
Cindy NEUZILLET, FR
- Medical nutrition in lower GI cancer care pathways: best practices with
Albert Wolthuis, BE
- Collegial discussion on integrated treatment pathways in GI cancer with the Expert Panel

Discussant: Eric Van Cutsem, BE

This session provides essential insights into embedding medical nutrition across the entire care continuum to improve patient outcomes and treatment tolerance.

✅ Free of charge and CME accredited.

This activity is supported by an educational grant from Fresenius Kabi.

13/05/2026

We are pleased to announce that our two webinars dedicated to the evolving field of MRD in Multiple Myeloma are now available for on-demand viewing on OncoCorner.

👉🏼 Part 1: Foundations and Clinical Relevance Explore the biological basis of MRD and its current impact on clinical decision-making.
🔗 Watch here: https://www.oncocorner.net/index.php?p=events&id=A-525

👉🏼 Part 2: Future Directions and Controversies A deep dive into emerging technologies, standardisation challenges, and the future of MRD-driven therapy.
🔗 Watch here: https://www.oncocorner.net/index.php?p=events&id=A-526

✅ Free of charge
✅ CME Accredited

This activity is supported by: an independent grant from Cloud Pathology Group and by an unrestricted medical contribution from Sanofi (Phase 1); by an unrestricted medical contribution from Sanofi, with procedures ongoing for the finalisation of further independent support from a second company (Phase 2).

11/05/2026

Last Saturday, we concluded an inspiring second edition of our course, "Leading innovation for better outcomes and performance in cancer care," designed for SPCC by SDA Bocconi.

Under the leadership of SPCC President Dr Matti Aapro, this initiative continues to push the boundaries of medical education. As our CEO Pietro Presti, MBA, PhD highlighted during the session, creating a real impact through innovation requires a profound shift in culture and management.

The discussions moved beyond metrics, reminding us that KPIs are tools for dialogue that help us ask better questions and make more informed decisions for our patients.

From multidisciplinary collaboration to the essential role of medical nutrition in supporting treatment tolerance, the programme challenged us to think "out of the box" and bridge the gap between academic research and real-world management.

A heartfelt thank you to our exceptional faculty, Lucia Ferrara, Elisabetta Trinchero, and Marco Pierotti, for their invaluable insights, and to all the participants for their energy and commitment to advancing the future of oncology.

This course was made possible thanks to the unrestricted support from Roche (Main Sponsor), Amgen, AstraZeneca S.p.A. and Cloud Pathology Group (Contributors).

05/05/2026

Save the date for the next webinar part of the Definitive Trial Project!

On Tuesday 16 June at 18:00 CEST, we will delve into the transformative role of HER2DX in bridging the gap between genomic complexity and everyday therapeutic decisions.

Professor Aleix Prat will lead a deep dive into the biological foundations of this assay alongside experts Francesco Schettini and Marta González, exploring how translating tumour genomics into risk stratification can fundamentally refine our treatment strategies. From the initial biological bases to the latest clinical perspectives, this session is designed to provide a multidisciplinary framework for more personalised breast cancer care.

👇🏼 Secure your place now to join the conversation 👇🏼 https://www.oncocorner.net/index.php?p=events&id=A-528

Funded by the European Union – Horizon Europe Grant Agreement No. 101136953. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them. This work has also received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).

30/04/2026

Malnutrition significantly impacts treatment outcomes and quality of life for patients with gastrointestinal cancers. However, structured nutritional care remains inconsistently integrated into clinical practice.

Join our upcoming webinar, "GI oncology pathways: from prehab to advanced cancer", to explore multidisciplinary best practices for embedding medical nutrition across the care continuum.

Discussant: Eric Van Cutsem (BE)
Experts: Cindy NEUZILLET (FR) and Albert Wolthuis (BE)

📅 Tuesday, 19 May 2026 | 18:00 CEST

This activity is supported by an educational grant from Fresenius Kabi.

👉 Register here: https://lnkd.in/dbdGT8SQ

20/04/2026

Missed our live session with All.Can? You can now watch the full webinar at your convenience on OncoCorner.

This session explores the essential organisational models and practical strategies needed to bridge the gap between innovation and everyday clinical reality. Our expert panel discusses how to ensure the sustainable implementation of precision medicine to improve patient outcomes.

Watch now free of charge 👉🏼 https://www.oncocorner.net/index.php?p=events&id=A-529

This session is part of the SPCC Sustaining Corporate Programme 2026. Sharing Progress in Cancer Care wishes to extend appreciation to its Sustaining Companies for providing unrestricted educational support to the following webinar. Companies have no control over the session content or speakers.

13/04/2026

Did you know malnutrition affects the majority of GI cancer patients? Improve your patient management with evidence-based nutritional pathways. Join Prof. Eric Van Cutsem and experts on 19 May.

👉🏼 https://www.oncocorner.net/index.php?p=events&id=A-530

This activity is supported by an educational grant from Fresenius Kabi.

Adresse

Via Vincenzo Vela 6
Bellinzona
6500

Telefon

+41918200968

Webseite

http://www.spcc.net/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Sharing Progress in Cancer Care erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.